Skip to content

Development of Standards for the New Ballard Maturation Score

Development of Standards for the New Ballard Maturation Score

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01203449
Acronym
Ballard
Enrollment
1090
Registered
2010-09-16
Start date
1994-06-30
Completion date
1996-03-31
Last updated
2015-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infant, Low Birth Weight, Infant, Newborn, Infant, Premature, Infant, Small for Gestational Age, Pregnancy

Keywords

NICHD Neonatal Research Network, Extremely Low Birth Weight (ELBW), Prematurity, Gestational Age

Brief summary

The primary purpose of this study was to evaluate the accuracy of gestational age (GA) estimates by using the New Ballard Score (NBS) in newborns 24 to 27 weeks GA with accurate obstetric estimates of GA. Secondary purposes were: (1) to compare the accuracy of GA estimates derived from the NBS, the original Ballard score, and the physical items of the original Ballard score and (2) to compare these measures of GA and best obstetric estimates of GA as predictors of survival, morbidity, and hospital stay among infants \<28 weeks' gestation and among very low birth weight infants in general.

Detailed description

The Ballard maturational assessment is commonly used to estimate gestational age (GA) when the menstrual history and other obstetrical estimates of GA are uncertain. The original Ballard Score and the New Ballard Score are based on the assumption that the fetal skin, subcutaneous tissues, and neuromuscular system mature at predictable rates. Because of variation in maturation rates among healthy fetuses or abnormalities of fetal development, fetal maturation can vary at a given GA. For very premature infants, small differences in GA result in large differences in outcome and may even determine whether intensive care is given. The primary purpose of this study was to evaluate the accuracy of GA estimates by using the NBS in newborns 24 to 27 weeks GA with accurate obstetric estimates of GA. Secondary purposes were: (1) to compare the accuracy of GA estimates derived from the NBS, the original Ballard score, and the physical items of the original Ballard score and (2) to compare these measures of GA and best obstetric estimates of GA as predictors of survival, morbidity, and hospital stay among infants \<28 weeks' gestation and among very low birth weight infants in general. For this study, eligible infants included those with birth weights of 401-1500g born in the National Institute of Child and Human Development (NICHD) Neonatal Research Network (NRN). Before 48 hours of age, enrolled infants were examined using the New Ballard Score by trained and certified research nurses masked to obstetric estimates of gestational age. A best obstetrical estimate of GA, used for screening of potentially eligible infants, was determined from the last menstrual period, obstetrical measures, and ultrasound findings recorded on the labor and delivery records.

Interventions

None listed

Sponsors

National Center for Research Resources (NCRR)
CollaboratorNIH
NICHD Neonatal Research Network
Lead SponsorNETWORK

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 48 Hours
Healthy volunteers
Yes

Inclusion criteria

* \<28 weeks gestational age by best obstetrical estimate * Availability of mother's prenatal records for review * First prenatal visit occurred before 17 weeks' gestation * Mother's menstrual history allowed calculation of GA at birth * Mother reported the duration of her usual menstrual cycles as 21 to 35 days * Mother had 3 consecutive normal menstrual cycles before the missed menstrual period identifying the index pregnancy * Mother reported that she was certain within 4 days of the first day of the last menstrual period (as recorded at the time of the first prenatal visit) * Mother denied use of birth control medication during the 3 months preceding the last menstrual period.

Exclusion criteria

* Inaccurate or unavailable menstrual histories

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026